Achilles Tendon Xanthoma: Familial Hypercholesterolemia, Diagnosis, and Cardiovascular Risk

Achilles tendon xanthoma is a cholesterol-laden deposit within the Achilles tendon substance, producing a characteristic fusiform (spindle-shaped) thickening that is firm, non-tender, and grows progressively over years. Unlike tendinopathy or tenosynovitis, xanthoma formation is not the result of mechanical overuse or inflammatory arthritis — it is a pathological consequence of systemic dyslipidemia, most commonly familial hypercholesterolemia (FH), in which elevated circulating LDL-cholesterol leads to macrophage uptake of oxidized LDL and deposition of cholesterol esters within tendons, skin, and other connective tissues. Achilles tendon xanthomas are present in approximately 20-50% of patients with untreated heterozygous familial hypercholesterolemia and in nearly all patients with homozygous FH — making their presence a clinical sign that should prompt lipid evaluation and cardiovascular risk assessment, not just local tendon management. The xanthoma itself rarely causes tendon rupture but does serve as a marker of systemic cholesterol burden and cardiovascular disease risk.

Achilles Tendon Xanthoma: Differential Diagnosis and Clinical Features

Feature	Achilles Xanthoma	Achilles Tendinopathy	Achilles Tendon Lipoma	Rheumatoid Nodule
Location	Within the tendon substance (intratendinous); typically mid-portion of Achilles 2-6 cm above insertion; may extend to insertion in severe FH	Mid-portion 2-6 cm above insertion (classic); or at calcaneal insertion; no lipid deposit	Superficial to tendon in paratenon or subcutaneous tissue; separate from tendon fibers; very rare	Subcutaneous; over bony prominence or extensor tendon surfaces; separate from tendon fibers; associated with RA
Consistency	Firm, nodular, non-compressible; does not move separately from tendon; tendon is diffusely thickened	Fusiform soft tissue swelling within tendon; may be slightly tender; painful arc sign positive	Soft, lobulated, compressible; easily moved relative to tendon; not painful	Firm, rubbery subcutaneous nodule; fixed to skin; over pressure point
Symptoms	Usually asymptomatic; occasionally mild posterior ankle fullness; NO significant pain or stiffness; tendon function preserved; patient often unaware	Significant activity-related pain; morning stiffness; pain with compression (Royal London test); functional limitation	Asymptomatic; occasional mild fullness; no pain	Usually asymptomatic; may become irritated with shoe pressure; associated with active RA
Bilateral	Frequently bilateral (FH affects both tendons equally); compare bilateral Achilles — asymmetry or bilateral thickening suggests metabolic etiology	Usually unilateral; bilateral possible in runners with training errors or bilateral equinus	Unilateral; no systemic association	Multiple; symmetric distribution in RA
Diagnostic context	Patient may have cutaneous xanthomas (yellow plaques on elbows, knees — xanthelasma on eyelids); elevated total cholesterol and LDL on lipid panel; family history premature cardiovascular disease; corneal arcus in young adults	Runner or active patient; training error history; tight calf; no lipid abnormality	No lipid association; isolated finding	Rheumatoid factor positive; anti-CCP positive; joint involvement; methotrexate/biologics history
Ultrasound	Diffuse hypoechoic thickening of Achilles tendon on ultrasound; intratendinous hyperechoic foci (cholesterol crystals); tendon width >8mm; no Doppler flow	Hypoechoic fusiform thickening; neovascularization on Doppler (active tendinopathy); normal fibrillar pattern disrupted	Hyperechoic mass separate from tendon; compressible; no intratendinous location	Hypoechoic nodule subcutaneous; separate from tendon

Achilles Xanthoma and Familial Hypercholesterolemia: Systemic Implications and Management

Topic	Detail
Familial hypercholesterolemia (FH) association	FH (LDL receptor gene mutation) causes severely elevated LDL from birth; heterozygous FH: LDL 190-350 mg/dL; homozygous FH: LDL >500 mg/dL; prevalence heterozygous FH 1:250-500; Achilles xanthomas present in 20-50% heterozygous FH adults, nearly 100% homozygous FH; Dutch Lipid Clinic Network criteria include tendon xanthoma as major diagnostic criterion for FH
Cardiovascular risk significance	Achilles xanthoma = marker of cumulative LDL burden; patients with Achilles xanthomas have substantially elevated cardiovascular risk (myocardial infarction risk 20x general population if untreated); presence of xanthoma should prompt urgent cardiology referral and aggressive lipid-lowering therapy; do not dismiss as incidental finding
Lipid workup prompted by xanthoma	Fasting lipid panel (total cholesterol, LDL, HDL, triglycerides); family history of premature MI (<55 years in males, <65 in females); genetic testing for LDL receptor mutation; lipoprotein(a) level; apolipoproteins; screening of first-degree relatives
Treatment of xanthoma	Lipid-lowering therapy (high-intensity statins, ezetimibe, PCSK9 inhibitors) reduces xanthoma size over years and lowers cardiovascular risk — the primary goal; local surgery for xanthoma excision is rarely indicated and does NOT reduce cardiovascular risk; tendon rupture prophylaxis: avoid fluoroquinolone antibiotics (worsen tendon degeneration); xanthoma does not require rupture prophylaxis surgery
Tendon rupture risk	Achilles xanthoma slightly increases tendon rupture risk (weakened fibers from lipid infiltration); standard Achilles tendon precautions apply; aggressive eccentric loading programs are not recommended in severely enlarged xanthomatous tendons; fluoroquinolones are relatively contraindicated (increase rupture risk in compromised tendons)

At Balance Foot & Ankle in Howell and Bloomfield Hills, bilateral painless Achilles tendon thickening without a history of tendinopathy prompts consideration of xanthoma from familial hypercholesterolemia — a finding that redirects clinical management from local tendon treatment to urgent lipid evaluation and cardiovascular risk assessment, since untreated FH carries a 20-fold increase in premature myocardial infarction risk. Call (810) 206-1402.

For a complete clinical overview: Ankle Pain Conditions Guide — location-by-location ankle pain diagnosis and treatment